GCTK
Conviction 20HealthcareScan · Thu, Sep 24, 2026Glucotrack, Inc. (GCTK) closed at $2.57 (+26.60%) on Sep 24, 2026. Its latest daily candle is a inverted hammer. Price is below its 50-day and below its 200-day moving average. RSI(14) 39, RS Rating 1, -98.0% from its 52-week high, -95.6% year to date. Sector: Healthcare · Surgical & Medical Instruments & Apparatus.
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- Glucotrack, Inc. Announces Pricing of $3 Million Public OfferingYahoo Finance · Thu, Sep 24, 2026
- Glucotrack Stock Is Trending: Here's Why GCTK Jumped Over 80% After HoursBenzinga · Thu, Sep 24, 2026
- Form 8K GlucoTrack Inc For: 23 September By Investing.comInvesting.com India · Wed, Sep 23, 2026
- GlucoTrack and Lōkahi Outline Post-Merger Strategic FocusTipRanks · Wed, Sep 23, 2026
- Glucotrack, Inc.: Merger agreementSEC EDGAR · Wed, Sep 23, 2026
- Glucotrack, Inc.: 8-K filedSEC EDGAR · Wed, Sep 23, 2026
- Shelved drug trove powers Glucotrack (NASDAQ: GCTK) ai² search for new therapiesStock Titan · Wed, Sep 23, 2026
- Lōkahi Therapeutics™ and Glucotrack CEO Erik Emerson Provides Strategic Update on LT-100, ai² Platform Growth and Clinical Development PrioritiesYahoo Finance · Wed, Sep 23, 2026
Congress activity
Disclosed STOCK Act trades in GCTK
Insider activity
SEC Form 4 transactions in GCTK
SEC filings
EDGAR filings in GCTK · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.